Skip to main content
. 2020 Jan 17;2020(1):CD011919. doi: 10.1002/14651858.CD011919.pub2
Study ID Intervention(s) and comparator(s) Participants included in analysis
 (N) Participants with a specific adverse event
 (description) Participants with at least one specific adverse events
 (N) Participants with at least one specific adverse event
 (%)
Timmers 2016 I: trans‐resveratrol + oral hypoglycaemic agent(s) or diet alone 17 0 0 0
C: placebo + oral hypoglycaemic agent(s) or diet alone 17 0 0 0
Thazhath 2016 I: resveratrol 14 0 0 0
C: placebo 14 0 0 0
Brasnyo 2011 I: trans‐resveratrol 10 0 0 0
C: placebo 9 0 0 0
— denotes not reported.
C: comparator, I: intervention.